STING1 and hepatocellular carcinoma: Notably, mitoxantrone (MIT) has demonstrated potential to stimulate cGAS-STING signaling, with studies confirming the feasibility of co-delivering MIT and NAP via nanoparticles for synergistic chemoimmunotherapy in HCC (166).